They suggested that the reduction in the inhibitory effect of dopamine in the hypothalamus can be a reason for inappropriate increased levels of LH and prolactin in PCOS patients with hyperprolactinemia (32). This evidence concerns the gene PLOD1 and hyperprolactinemia.